SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
SK Hynix Shares Fall as Workers Reject Wage Deal 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Trump Buys SpaceX Shares After Record IPO 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Add as a preferred source on Google
SAN FRANCISCO, April 19, 2018 -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 first quarter financial results after the market closes on Thursday, May 3, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Thursday, May 3, 2018, to discuss the financial results and other business developments.
Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 9299518. To listen to the live call via Invuity's website, go to www.invuity.com, in the Events & Presentations section. A webcast replay of the call will be available following the conclusion of the call in the Events & Presentations section of the website.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The Company’s patented Intelligent Photonics® technology delivers enhanced visualization, which facilitates surgical precision, efficiency and safety. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic and general surgery. Invuity is headquartered in San Francisco, CA.
CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129
Investors:
Mark Klausner
Westwicke Partners
443-213-0501
[email protected]
